Insmed (INSM) PT Raised to $195 at Truist Securities
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $126.29 -0.31%
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Rating Summary:
32 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Join SI Premium – FREE
Truist Securities analyst Danielle Brill raised the price target on Insmed (NASDAQ: INSM) to $195.00 (from $185.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Covivio (COV:FP) to Buy
- Daicel Corporation (4202:JP) (DACHF) PT Raised to JPY1,520 at Nomura/Instinet
- Nippon Yusen Kabushiki Kaisha (9101:JP) (NPNYY) PT Raised to JPY8,800 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
